Industry: Chemical & Material
Published Date: 2024-12-26
Pages: 170 Pages
Report ld: 3410296
Request Sample
Customized Report
Lipid Nanoparticle (LNP) Raw Material Market Size(US$)

CAGR 2024-2030
12.5%
Market Size,2030
USD 269
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Valued at US$ 133 million in 2024, the global Lipid Nanoparticle (LNP) Raw Material market is forecast to reach US$ 269 million by 2030, at a CAGR of 12.5% during the forecast period.
The most widely used components of LNP include polyethylene glycol lipids, cholesterol, synthetic phospholipids, and ionizable cationic lipids. Cationic lipids, which bind to negatively charged mRNA, are the most critical components of LNP; Cholesterol mediates the internalization of LNP and stabilizes the structure of LNP (cholesterol helps increase the fluidity or hardness of cell membranes, and adding cholesterol can improve the stability of nanoparticles); Phosphatidylcholine, a helper lipid, can accelerate mRNA release during endocytosis; Polyethylene glycol lipids prolong metabolism time and improve LNP stability.
The US & Canada market for Lipid Nanoparticle (LNP) Raw Material is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Lipid Nanoparticle (LNP) Raw Material is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Lipid Nanoparticle (LNP) Raw Material is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Lipid Nanoparticle (LNP) Raw Material include Merck KGaA, CordenPharma, Croda, Cayman Chemical Company, Avanti Polar Lipids, Tebubio, Creative Biolabs, Biopharma PEG, Polysciences, CD Bioparticles, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Lipid Nanoparticle (LNP) Raw Material production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Lipid Nanoparticle (LNP) Raw Material by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Lipid Nanoparticle (LNP) Raw Material, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Lipid Nanoparticle (LNP) Raw Material, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Lipid Nanoparticle (LNP) Raw Material, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lipid Nanoparticle (LNP) Raw Material sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Lipid Nanoparticle (LNP) Raw Material market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Lipid Nanoparticle (LNP) Raw Material sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck KGaA, CordenPharma, Croda, Cayman Chemical Company, Avanti Polar Lipids, Tebubio, Creative Biolabs, Biopharma PEG, Polysciences, CD Bioparticles, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Lipid Nanoparticle (LNP) Raw Material production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Lipid Nanoparticle (LNP) Raw Material in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Lipid Nanoparticle (LNP) Raw Material manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticle (LNP) Raw Material sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Lipid Nanoparticle (LNP) Raw Material Product Introduction
1.2 Market by Type
1.2.1 Global Lipid Nanoparticle (LNP) Raw Material Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Cationic Lipid
1.2.3 Cholesterol
1.2.4 PEG Lipid
1.2.5 DSPC Lipid
1.3 Market by Application
1.3.1 Global Lipid Nanoparticle (LNP) Raw Material Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 siRNA-lipid Nanoparticle
1.3.3 mRNA-lipid Nanoparticle
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Lipid Nanoparticle (LNP) Raw Material Production
2.1 Global Lipid Nanoparticle (LNP) Raw Material Production Capacity (2019-2030)
2.2 Global Lipid Nanoparticle (LNP) Raw Material Production by Region: 2019 VS 2023 VS 2030
2.3 Global Lipid Nanoparticle (LNP) Raw Material Production by Region
2.3.1 Global Lipid Nanoparticle (LNP) Raw Material Historic Production by Region (2019-2024)
2.3.2 Global Lipid Nanoparticle (LNP) Raw Material Forecasted Production by Region (2025-2030)
2.3.3 Global Lipid Nanoparticle (LNP) Raw Material Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Lipid Nanoparticle (LNP) Raw Material Revenue Estimates and Forecasts 2019-2030
3.2 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Region
3.2.1 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Region (2019-2024)
3.2.3 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Region (2025-2030)
3.2.4 Global Lipid Nanoparticle (LNP) Raw Material Revenue Market Share by Region (2019-2030)
3.3 Global Lipid Nanoparticle (LNP) Raw Material Sales Estimates and Forecasts 2019-2030
3.4 Global Lipid Nanoparticle (LNP) Raw Material Sales by Region
3.4.1 Global Lipid Nanoparticle (LNP) Raw Material Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Lipid Nanoparticle (LNP) Raw Material Sales by Region (2019-2024)
3.4.3 Global Lipid Nanoparticle (LNP) Raw Material Sales by Region (2025-2030)
3.4.4 Global Lipid Nanoparticle (LNP) Raw Material Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Lipid Nanoparticle (LNP) Raw Material Sales by Manufacturers
4.1.1 Global Lipid Nanoparticle (LNP) Raw Material Sales by Manufacturers (2019-2024)
4.1.2 Global Lipid Nanoparticle (LNP) Raw Material Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lipid Nanoparticle (LNP) Raw Material in 2023
4.2 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Manufacturers
4.2.1 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Manufacturers (2019-2024)
4.2.2 Global Lipid Nanoparticle (LNP) Raw Material Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Lipid Nanoparticle (LNP) Raw Material Revenue in 2023
4.3 Global Lipid Nanoparticle (LNP) Raw Material Sales Price by Manufacturers (2019-2024)
4.4 Global Key Players of Lipid Nanoparticle (LNP) Raw Material, Industry Ranking, 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Lipid Nanoparticle (LNP) Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Lipid Nanoparticle (LNP) Raw Material, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Lipid Nanoparticle (LNP) Raw Material, Product Offered and Application
4.8 Global Key Manufacturers of Lipid Nanoparticle (LNP) Raw Material, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Lipid Nanoparticle (LNP) Raw Material Sales by Type
5.1.1 Global Lipid Nanoparticle (LNP) Raw Material Historical Sales by Type (2019-2024)
5.1.2 Global Lipid Nanoparticle (LNP) Raw Material Forecasted Sales by Type (2025-2030)
5.1.3 Global Lipid Nanoparticle (LNP) Raw Material Sales Market Share by Type (2019-2030)
5.2 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Type
5.2.1 Global Lipid Nanoparticle (LNP) Raw Material Historical Revenue by Type (2019-2024)
5.2.2 Global Lipid Nanoparticle (LNP) Raw Material Forecasted Revenue by Type (2025-2030)
5.2.3 Global Lipid Nanoparticle (LNP) Raw Material Revenue Market Share by Type (2019-2030)
5.3 Global Lipid Nanoparticle (LNP) Raw Material Price by Type
5.3.1 Global Lipid Nanoparticle (LNP) Raw Material Price by Type (2019-2024)
5.3.2 Global Lipid Nanoparticle (LNP) Raw Material Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Lipid Nanoparticle (LNP) Raw Material Sales by Application
6.1.1 Global Lipid Nanoparticle (LNP) Raw Material Historical Sales by Application (2019-2024)
6.1.2 Global Lipid Nanoparticle (LNP) Raw Material Forecasted Sales by Application (2025-2030)
6.1.3 Global Lipid Nanoparticle (LNP) Raw Material Sales Market Share by Application (2019-2030)
6.2 Global Lipid Nanoparticle (LNP) Raw Material Revenue by Application
6.2.1 Global Lipid Nanoparticle (LNP) Raw Material Historical Revenue by Application (2019-2024)
6.2.2 Global Lipid Nanoparticle (LNP) Raw Material Forecasted Revenue by Application (2025-2030)
6.2.3 Global Lipid Nanoparticle (LNP) Raw Material Revenue Market Share by Application (2019-2030)
6.3 Global Lipid Nanoparticle (LNP) Raw Material Price by Application
6.3.1 Global Lipid Nanoparticle (LNP) Raw Material Price by Application (2019-2024)
6.3.2 Global Lipid Nanoparticle (LNP) Raw Material Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Lipid Nanoparticle (LNP) Raw Material Market Size by Type
7.1.1 US & Canada Lipid Nanoparticle (LNP) Raw Material Sales by Type (2019-2030)
7.1.2 US & Canada Lipid Nanoparticle (LNP) Raw Material Revenue by Type (2019-2030)
7.2 US & Canada Lipid Nanoparticle (LNP) Raw Material Market Size by Application
7.2.1 US & Canada Lipid Nanoparticle (LNP) Raw Material Sales by Application (2019-2030)
7.2.2 US & Canada Lipid Nanoparticle (LNP) Raw Material Revenue by Application (2019-2030)
7.3 US & Canada Lipid Nanoparticle (LNP) Raw Material Market Size by Country
7.3.1 US & Canada Lipid Nanoparticle (LNP) Raw Material Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Lipid Nanoparticle (LNP) Raw Material Revenue by Country (2019-2030)
7.3.3 US & Canada Lipid Nanoparticle (LNP) Raw Material Sales by Country (2019-2030)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Lipid Nanoparticle (LNP) Raw Material Market Size by Type
8.1.1 Europe Lipid Nanoparticle (LNP) Raw Material Sales by Type (2019-2030)
8.1.2 Europe Lipid Nanoparticle (LNP) Raw Material Revenue by Type (2019-2030)
8.2 Europe Lipid Nanoparticle (LNP) Raw Material Market Size by Application
8.2.1 Europe Lipid Nanoparticle (LNP) Raw Material Sales by Application (2019-2030)
8.2.2 Europe Lipid Nanoparticle (LNP) Raw Material Revenue by Application (2019-2030)
8.3 Europe Lipid Nanoparticle (LNP) Raw Material Market Size by Country
8.3.1 Europe Lipid Nanoparticle (LNP) Raw Material Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Lipid Nanoparticle (LNP) Raw Material Sales by Country (2019-2030)
8.3.3 Europe Lipid Nanoparticle (LNP) Raw Material Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Lipid Nanoparticle (LNP) Raw Material Market Size by Type
9.1.1 China Lipid Nanoparticle (LNP) Raw Material Sales by Type (2019-2030)
9.1.2 China Lipid Nanoparticle (LNP) Raw Material Revenue by Type (2019-2030)
9.2 China Lipid Nanoparticle (LNP) Raw Material Market Size by Application
9.2.1 China Lipid Nanoparticle (LNP) Raw Material Sales by Application (2019-2030)
9.2.2 China Lipid Nanoparticle (LNP) Raw Material Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Lipid Nanoparticle (LNP) Raw Material Market Size by Type
10.1.1 Asia Lipid Nanoparticle (LNP) Raw Material Sales by Type (2019-2030)
10.1.2 Asia Lipid Nanoparticle (LNP) Raw Material Revenue by Type (2019-2030)
10.2 Asia Lipid Nanoparticle (LNP) Raw Material Market Size by Application
10.2.1 Asia Lipid Nanoparticle (LNP) Raw Material Sales by Application (2019-2030)
10.2.2 Asia Lipid Nanoparticle (LNP) Raw Material Revenue by Application (2019-2030)
10.3 Asia Lipid Nanoparticle (LNP) Raw Material Market Size by Region
10.3.1 Asia Lipid Nanoparticle (LNP) Raw Material Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Lipid Nanoparticle (LNP) Raw Material Revenue by Region (2019-2030)
10.3.3 Asia Lipid Nanoparticle (LNP) Raw Material Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Market Size by Type
11.1.1 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Market Size by Application
11.2.1 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Market Size by Country
11.3.1 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Lipid Nanoparticle (LNP) Raw Material Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Merck KGaA
12.1.1 Merck KGaA Corporation Information
12.1.2 Merck KGaA Overview
12.1.3 Merck KGaA Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Merck KGaA Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Merck KGaA Recent Developments
12.2 CordenPharma
12.2.1 CordenPharma Corporation Information
12.2.2 CordenPharma Overview
12.2.3 CordenPharma Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 CordenPharma Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 CordenPharma Recent Developments
12.3 Croda
12.3.1 Croda Corporation Information
12.3.2 Croda Overview
12.3.3 Croda Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Croda Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Croda Recent Developments
12.4 Cayman Chemical Company
12.4.1 Cayman Chemical Company Corporation Information
12.4.2 Cayman Chemical Company Overview
12.4.3 Cayman Chemical Company Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Cayman Chemical Company Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Cayman Chemical Company Recent Developments
12.5 Avanti Polar Lipids
12.5.1 Avanti Polar Lipids Corporation Information
12.5.2 Avanti Polar Lipids Overview
12.5.3 Avanti Polar Lipids Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Avanti Polar Lipids Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Avanti Polar Lipids Recent Developments
12.6 Tebubio
12.6.1 Tebubio Corporation Information
12.6.2 Tebubio Overview
12.6.3 Tebubio Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Tebubio Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Tebubio Recent Developments
12.7 Creative Biolabs
12.7.1 Creative Biolabs Corporation Information
12.7.2 Creative Biolabs Overview
12.7.3 Creative Biolabs Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Creative Biolabs Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Creative Biolabs Recent Developments
12.8 Biopharma PEG
12.8.1 Biopharma PEG Corporation Information
12.8.2 Biopharma PEG Overview
12.8.3 Biopharma PEG Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Biopharma PEG Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Biopharma PEG Recent Developments
12.9 Polysciences
12.9.1 Polysciences Corporation Information
12.9.2 Polysciences Overview
12.9.3 Polysciences Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Polysciences Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Polysciences Recent Developments
12.10 CD Bioparticles
12.10.1 CD Bioparticles Corporation Information
12.10.2 CD Bioparticles Overview
12.10.3 CD Bioparticles Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 CD Bioparticles Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 CD Bioparticles Recent Developments
12.11 Nippon Fine Chemical
12.11.1 Nippon Fine Chemical Corporation Information
12.11.2 Nippon Fine Chemical Overview
12.11.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.11.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Nippon Fine Chemical Recent Developments
12.12 Dishman
12.12.1 Dishman Corporation Information
12.12.2 Dishman Overview
12.12.3 Dishman Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.12.4 Dishman Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Dishman Recent Developments
12.13 Beijing Jenkem Technology
12.13.1 Beijing Jenkem Technology Corporation Information
12.13.2 Beijing Jenkem Technology Overview
12.13.3 Beijing Jenkem Technology Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.13.4 Beijing Jenkem Technology Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Beijing Jenkem Technology Recent Developments
12.14 SINOPEG
12.14.1 SINOPEG Corporation Information
12.14.2 SINOPEG Overview
12.14.3 SINOPEG Lipid Nanoparticle (LNP) Raw Material Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.14.4 SINOPEG Lipid Nanoparticle (LNP) Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 SINOPEG Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Lipid Nanoparticle (LNP) Raw Material Industry Chain Analysis
13.2 Lipid Nanoparticle (LNP) Raw Material Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Lipid Nanoparticle (LNP) Raw Material Production Mode & Process
13.4 Lipid Nanoparticle (LNP) Raw Material Sales and Marketing
13.4.1 Lipid Nanoparticle (LNP) Raw Material Sales Channels
13.4.2 Lipid Nanoparticle (LNP) Raw Material Distributors
13.5 Lipid Nanoparticle (LNP) Raw Material Customers
14 Lipid Nanoparticle (LNP) Raw Material Market Dynamics
14.1 Lipid Nanoparticle (LNP) Raw Material Industry Trends
14.2 Lipid Nanoparticle (LNP) Raw Material Market Drivers
14.3 Lipid Nanoparticle (LNP) Raw Material Market Challenges
14.4 Lipid Nanoparticle (LNP) Raw Material Market Restraints
15 Key Findings in the Global Lipid Nanoparticle (LNP) Raw Material Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Lipid Nanoparticle (LNP) Raw Material market is projected to grow from US$ 148 million in 2025 to US$ 333 million by 2032, at a CAGR of 12.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 166
USD 4900.00
(Single User License)
The global Lipid Nanoparticle (LNP) Raw Material market size was US$ 148 million in 2025 and is forecast to reach a readjusted size of US$ 333 million by 2032 with a CAGR of 12.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 94
USD 4250.00
(Single User License)
The global market for Lipid Nanoparticle (LNP) Raw Material was estimated to be worth US$ 148 million in 2025 and is projected to reach US$ 333 million, growing at a CAGR of 12.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 118
USD 3950.00
(Single User License)
The global Lipid Nanoparticle (LNP) Raw Material market was valued at US$ 148 million in 2025 and is anticipated to reach US$ 333 million by 2032, at a CAGR of 12.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 139
USD 2900.00
(Single User License)
The global Lipid Nanoparticle (LNP) Raw Material market is projected to grow from US$ 133 million in 2024 to US$ 299 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 158
USD 4900.00
(Single User License)
The global Lipid Nanoparticle (LNP) Raw Material market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 299 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 97
USD 4250.00
(Single User License)
The global market for Lipid Nanoparticle (LNP) Raw Material was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 299 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 121
USD 3950.00
(Single User License)
The global market for Lipid Nanoparticle (LNP) Raw Material was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 299 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
The global market for Lipid Nanoparticle (LNP) Raw Material was valued at US$ 120 million in the year 2023 and is projected to reach a revised size of US$ 269 million by 2030, growing at a CAGR of 12.5% during the forecast period.
Published Date: 2024-12-26
Pages: 103
USD 2900.00
(Single User License)
The global market for Lipid Nanoparticle (LNP) Raw Material was estimated to be worth US$ 120 million in 2023 and is forecast to a readjusted size of US$ 269 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030.
Published Date: 2024-12-26
Pages: 121
USD 3950.00
(Single User License)
The global Lipid Nanoparticle (LNP) Raw Material market is projected to grow from US$ 148 million in 2025 to US$ 333 million by 2032, at a CAGR of 12.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 166
The global Lipid Nanoparticle (LNP) Raw Material market size was US$ 148 million in 2025 and is forecast to reach a readjusted size of US$ 333 million by 2032 with a CAGR of 12.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 94
The global market for Lipid Nanoparticle (LNP) Raw Material was estimated to be worth US$ 148 million in 2025 and is projected to reach US$ 333 million, growing at a CAGR of 12.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 118
The global Lipid Nanoparticle (LNP) Raw Material market was valued at US$ 148 million in 2025 and is anticipated to reach US$ 333 million by 2032, at a CAGR of 12.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 139
The global Lipid Nanoparticle (LNP) Raw Material market is projected to grow from US$ 133 million in 2024 to US$ 299 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 158
The global Lipid Nanoparticle (LNP) Raw Material market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 299 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 97
The global market for Lipid Nanoparticle (LNP) Raw Material was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 299 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 121
The global market for Lipid Nanoparticle (LNP) Raw Material was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 299 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Published: 2025-03-10
Pages: 99
The global market for Lipid Nanoparticle (LNP) Raw Material was valued at US$ 120 million in the year 2023 and is projected to reach a revised size of US$ 269 million by 2030, growing at a CAGR of 12.5% during the forecast period.
Published: 2024-12-26
Pages: 103
The global market for Lipid Nanoparticle (LNP) Raw Material was estimated to be worth US$ 120 million in 2023 and is forecast to a readjusted size of US$ 269 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030.
Published: 2024-12-26
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now